首页> 外文会议>Proceedings of the 6th CCTCNM-KSP-JSP joint symposium on pharmacognosy >Validation of a gas chromatography-electron capture detection of T-2 and HT-2 toxins in Chinese herbal medicines and related products after immunoaffinity column clean-up and pre-column derivatization
【24h】

Validation of a gas chromatography-electron capture detection of T-2 and HT-2 toxins in Chinese herbal medicines and related products after immunoaffinity column clean-up and pre-column derivatization

机译:免疫亲和柱净化和柱前衍生化后气相色谱-电子捕获法检测中草药及相关产品中的T-2和HT-2毒素

获取原文
获取原文并翻译 | 示例

摘要

A sensitive, reproducible and accurate gas chromatography-electron capture detection (GC-ECD) method was developed for simultaneous determination of T-2 and HT-2 toxins in Chinese herbal medicines (CHMs) and related products. Then, gas chromatography-mass spectrometry (GC-MS) was applied to confirm the positive results and interfering peaks in some samples. All samples were injected into the Agilent GC-6890N gas system (Hewlett-Packard, Palo Alto, CA, USA), equipped with a 63Ni electron capture detector on a DB-1701 capillary column (30 m × 0.25 mm I.D., 0.25 urn film thickness, Agilent Technologies). The positive samples and interfering peaks in some samples were confirmed by GC-MS on a Varian 300 TQ Mass instrument (Agilent Varian Technologies, USA) coupled with a HP-5MS fused silica capillary column (30 m × 0.25 mm I.D., 0.25 μm film thickness, Agilent Technologies). The extraction solvent, clean-up column and pre-column derivatization conditions for T-2 and HT-2 toxins in all samples were optimized. Then, the established GC-ECD method used for T-2 and HT-2 toxins was validated for linearity, precision, selectivity and recovery. The optimized sampling methods were that extraction of samples with methanol/water (90:10, v/v), followed by immunoaffinity column (LAC) clean-up and pre-column derivatization with N-heptafluoro-butyryl imidazole (HFBI). And the optimized GC-ECD method was as follows: one microliter of the sample solution was injected into the chromatographic apparatus for analysis, the injector was operated in the splitless mode, the injector and detector temperatures were 270 °C and 300 °C, respectively, highpurity (over 99.99%) nitrogen at a flow-rate of 1.0 mL/min was used as the carrier gas, the column temperature was programmed as: 80 °C (hold for 2min), 10 °C/min to 200 °C, 5 °C /min to 220 °C, 2 °C/min to 230 °C (hold for 13 min), 3 °C/min to 270 °C, and 5 ° C/min up to 280 °C (hold for 5 min). The results showed that the limits of detection (LOD) of the validated GC-ECD method for T-2 and HT-2 toxins were 1.88 and 0.47 ng/g, respectively, and the recoveries for different CHMs spiked with 50, 100 and 1000 ng toxin/g ranged from 89.2% to 99.1% with relative standard deviations (RSD) < 6.0% for T-2 and from 85.9% to 99.0% with RSD < 8.8% for HT-2 toxin, respectively. The validated method was successfully applied for the determination of T-2 and HT-2 toxins in 89 Chinese herbal medicines and 10 related products including granula, pills and pulvises from different sources, where it was found that T-2 and HT-2 toxins were not detected (> LOD) in any of the tested samples. These results were reliable by confirmation using GC-MS. Some unknown peaks in Rhizoma Arisaematis and Raidix Scrophulariae were interfering peaks not the target toxins. This is a successful report for analyzing T-2 and HT2 toxins in CHMs and related products by GC-ECD. Future study would focus on the determination of more trichothecenes or mycotoxins in CHMs and related products to avoid health problems of these toxic materials in consumers.
机译:建立了灵敏,可重现和准确的气相色谱-电子捕获检测(GC-ECD)方法,用于同时测定中草药(CHMs)和相关产品中的T-2和HT-2毒素。然后,采用气相色谱-质谱法(GC-MS)确认阳性结果和某些样品中的干扰峰。将所有样品注入安捷伦GC-6890N气体系统(美国加利福尼亚州帕洛阿尔托的惠普公司),该系统在DB-1701毛细管柱上装有63Ni电子捕获检测器(30 m×0.25 mm内径,0.25 um膜)厚度,安捷伦科技公司)。在Varian 300 TQ Mass仪器(Agilent Varian Technologies,USA)上通过GC-MS与HP-5MS熔融石英毛细管色谱柱(30 m×0.25 mm ID,0.25μm膜)结合使用GC-MS确认阳性样品和某些样品中的干扰峰厚度,安捷伦科技公司)。优化了所有样品中T-2和HT-2毒素的提取溶剂,净化柱和柱前衍生条件。然后,验证了建立的用于T-2和HT-2毒素的GC-ECD方法的线性,精密度,选择性和回收率。优化的采样方法是先用甲醇/水(90:10,v / v)萃取样品,然后进行免疫亲和柱(LAC)净化和N-七氟丁酰咪唑(HFBI)的柱前衍生化。优化的GC-ECD方法如下:将一微升样品溶液注入色谱仪进行分析,进样器以不分流模式运行,进样器和检测器温度分别为270°C和300°C ,以1.0 mL / min的流速使用高纯度(99.99%以上)氮气作为载气,色谱柱温度设定为:80°C(保持2分钟),10°C / min至200°C ,5°C / min至220°C,2°C / min至230°C(保持13分钟),3°C / min至270°C和5°C / min至280°C(保持5分钟)。结果表明,经验证的GC-ECD方法对T-2和HT-2毒素的检出限(LOD)分别为1.88和0.47 ng / g,加标50、100和1000的不同CHM的回收率ng毒素/ g的T-2相对标准偏差(RSD)<6.0%,范围从89.2%至99.1%,而HT-2毒素的RSD <8.8%,相对标准偏差(RSD)从85.9%至99.0%。验证的方法成功地用于测定89种中草药和10种相关产品中的T-2和HT-2毒素,这些产品包括来自不同来源的颗粒,丸剂和粉刺,其中发现T-2和HT-2毒素在任何测试样品中均未检测到(> LOD)。通过使用GC-MS进行确认,这些结果是可靠的。 Arisaematis和Raidix玄参中的一些未知峰是干扰峰,而不是目标毒素。这是通过GC-ECD分析CHM和相关产品中的T-2和HT2毒素的成功报告。未来的研究将侧重于确定CHM和相关产品中更多的天花粉蛋白或霉菌毒素,以避免消费者中这些有毒物质的健康问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号